‹‹24››.
Benjamin MM, Roberts WC. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease.‹‹25››.
McMahan CA, Gidding SS, Malcom GT, et al. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis.‹‹26››.
Trumbo PR, Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol.‹‹27››.
Roberts WC. It’s the cholesterol, stupid!‹‹28››.
O’Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal.‹‹29››.
Esselstyn CB. In cholesterol lowering, moderation kills.‹‹30››.
Roberts WC. The cause of atherosclerosis.‹‹31››.
Roberts WC. The cause of atherosclerosis.‹‹32››.
King S. The best selling drugs since 1996 — why AbbVie’s Humira is set to eclipse Pfizer’s Lipitor. http://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfi zers-lipitor/. July 15, 2013. Accessed May 1, 2015.‹‹33››.
Ginter E, Kajaba I, Sauša M. Addition of statins into the public water supply? Risks of side effects and low cholesterol levels.‹‹34››.
Ferenczi EA, Asaria P, Hughes AD, Chaturvedi N, Francis DP. Can a statin neutralize the cardiovascular risk of unhealthy dietary choices?‹‹35››.
Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.‹‹36››.
Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in communitydwelling older adults.‹‹37››.
Jefferson E. FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. http://www.fda.gov/NewsEvents/Newsroom/Press_Announcements/ ucm293623.htm. February 28, 2012. Accessed February 14, 2015.‹‹38››.
McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.‹‹39››.
Jenkins DJ, Kendall CW, Marchie A, et al. The Garden of Eden — plant-based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century.‹‹40››.
Esselstyn CB. Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century?‹‹41››.
Kadoch MA. The power of nutrition as medicine.‹‹42››.
Wakai K, Marugame T, Kuriyama S, et al. Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies.‹‹43››.
Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects.‹‹44››.
Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4.‹‹45››.
Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease.‹‹46››.
Ornish D, Scherwitz LW, Doody RS, et al. Effects of stress management training and dietary changes in treating ischemic heart disease.‹‹47››.
Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease.‹‹48››.
Ellis FR, Sanders TA. Angina and vegan diet.‹‹49››.
Sweeney M. Effects of very low-fat diets on anginal symptoms.